The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis
Open accessAbstract
Deranged intestinal motility, which occurs in cirrhosis, may facilitate the development of intestinal bacterial overgrowth (IBO), which can lead to bacterial translocation (BT). To assess the effect of cisapride on IBO and BT in cirrhosis, cirrhotic rats received cisapride or a placebo for 7 days, and measurements of jejunal bacterial content and BT studies were performed. In addition, jejunal fluid from 46 cirrhotic patients was obtained for quantitative bacterial culture. Those patients in whom gram-negative IBO was detected were randomized to receive or not to receive cisapride (20 mg twice per day) for 1 week. Cisapride significantly reduced IBO in cirrhotic rats. In addition, no BT was documented in treated animals, whereas it occurred in 40% in nontreated cirrhotic rats. Total IBO was documented in 23 of 46 cirrhotic patients, which was caused by gram-negative organisms in 10 cases. Orocecal transit time (OCT) significantly decreased after cisapride therapy, and was associated with the abolishment of bacterial overgrowth caused by gram-negative organisms in 4 out of 5 treated patients, whereas it persisted in nontreated cases. Cisapride administration to cirrhotic rats resulted in a reduction of the IBO, which is associated with a marked decrease in BT. On the other hand, cisapride facilitates the abolition of IBO caused by gram-negative organisms in cirrhotic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prokinetic drug cisapride not only decreases intestinal transit time but also inhibits intestinal bacterial overgrowth and bacterial translocation, both in animal models150,151 and in patients with cirrhosis150,152.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [150]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, L., Li, N., & Ye, H. (2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,208
Vantrappen, G., Janssens, J., Hellemans, J., & Ghoos, Y. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108740 · Cited by 815
Ginés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Self-citationA prospective study of bacterial infections in patients with cirrhosis
Caly, W. R., & Strauss, E. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80280-6 · Cited by 504
Llovet, J. M., Bruix, J., Fuster, J., Castells, A., García‐Valdecasas, J. C., Grande, L., França, A. V. C., Brú, C., Navasa, M., Ayuso, M. D. C., et al. (1998) · Hepatology · doi:10.1002/hep.510270616 · Cited by 381
Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage
Soriano, G., Guarner, C., Tomás, A., Villanueva, C., Torras, X., González, D., Sáinz, S., Anguera, A., Cussó, X., Balanzó, J., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91514-5 · Cited by 314
Jejunal microflora in patients with chronic alcohol abuse.
Jc, B., Bode, C., Heidelbach, R., Hk, D., & Ga, M. (1984) · PubMed · Cited by 303
Obstructive jaundice promotes bacterial translocation from the gut
Deitch, E. A., Sittig, K. M., Ma, L., Berg, R. D., & Specian, R. D. (1990) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80610-5 · Cited by 300
Chang, C., Chen, G., Lien, H., & Yeh, H. (1998) · Hepatology · doi:10.1002/hep.510280504 · Cited by 261
Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites
García–Tsao, G., Lee, F., Barden, G. E., Cartun, R. W., & West, A. B. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90147-7 · Cited by 247
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 10
- Llovet, 1993, Am J Gastroenterol, 88, 388
- Runyon, 1995, Hepatology, 21, 1719
- Chesta, 1993, Hepatology, 17, 828
- Shindo, 1993, Am J Gastroenterol, 88, 2084
- Enteric bacterial flora and bacterial overgrowth syndrome. In: eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease 6th ed. Philadelphia: Saunders. 1998;1523-1535.
- Flexner, 1895, Johns Hopkins Hosp Bull, 6, 64
- Berg, 1992, J Med, 23, 217
- Bode, 1993, Z Gastroenterol, 31, 3
- Martini, 1956, Clin Sci, 16, 35
- McCallum, 1991, Am J Gastroenterol, 86, 135
Cited by
Sorted by citations
Items 101–177 of 177
Spontaneous Bacterial Peritonitis
Song, D. S. (2018) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2018.72.2.56 · Cited by 23
Gonzalez-Suarez, B. A., Guarner, C., Villanueva, C., Miñana, J. M., Soriano, G., Gallego, A., Sáinz, S., Torras, X., Cusso, X., & Balanzó, J. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00009 · Cited by 23
Sánchez, E., Nieto, J. C., Vidal, S., Santiago, A., Martínez, X., Sancho, F. J., Sancho‐Bru, P., Mirelis, B., Corominola, H., Juárez, C., et al. (2017) · Scientific Reports · doi:10.1038/srep45712 · Cited by 21
Seerden, T. C. J., Man, J. G. D., Holzer, P. D., den Bossche, R. M. V., Herman, A. G., Pelckmans, P. A., & Winter, B. Y. D. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00968.x · Cited by 21
Intestinal flora, probiotics, and cirrhosis
Guerrero-Hernández, I., Delgadillo, A. T., Vargas-Vorácková, F., & Uribe, M. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31866-6 · Cited by 21
Fisiopatología de la translocación y la peritonitis bacteriana espontánea en la cirrosis
Alonso, R. G., García, M. G., & Albillos, A. (2007) · Gastroenterología y Hepatología · doi:10.1157/13099277 · Cited by 21
Bacterial Infections in Cirrhosis
Tonon, M., Angeli, P., & Piano, S. S. (2021) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000065 · Cited by 19
Serper, M., Agha, A. Z., Garren, P. A., Taddei, T. H., Kaplan, D. E., Groeneveld, P. W., Werner, R. M., & Shea, J. A. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000157 · Cited by 18
Microbioma y traslocación bacteriana en la cirrosis
Gómez‐Hurtado, I., Such, J. M., & Francés, R. (2016) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2015.10.013 · Cited by 18
Hung, T., Tseng, C., Lee, H., Tsai, C., & Tsai, C.-C. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.7193 · Cited by 18
Zhang, Y., Lou, J.-W., An, K., Zhang, Q., Zhou, S.-K., Bao, B., Cao, Y., Yao, W., Tang, Y., & Zhang, L. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112423 · Cited by 18
Nagasako, C. K., Figueiredo, M. J. D. O., Almeida, J. R. S., Lorena, S. L. S., Akasaka, H. M. I., Pavan, C. R., Yamanaka, A., Sevá‐Pereira, T., Soares, E. C., & Mesquita, M. A. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31818de34c · Cited by 17
Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis
Li, Y., Huang, J., & Peng, M. (2020) · BioMed Research International · doi:10.1155/2020/3743962 · Cited by 17
Microbiome and bacterial translocation in cirrhosis
Gómez‐Hurtado, I., Such, J. M., & Francés, R. (2016) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2015.10.002 · Cited by 16
Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?
Senzolo, M., Nadal, E., Cholongitas, Ε., & Burroughs, A. K. (2011) · Hepatology · doi:10.1002/hep.24176 · Cited by 16
Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats
Òdena, G. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i17.2084 · Cited by 15
Microbial Infections as a Trigger for Acute-on-Chronic Liver Failure: A Review
Cai, Q., Liu, W., Zhu, M., & Sheng, J. (2019) · Medical Science Monitor · doi:10.12659/msm.915637 · Cited by 17
Increased oro-cecal transit time in grade I or II hepatic encephalopathy
Bouin, M., Vincent, C., Bouhier, K., Debruyne, D., Fatome, A., Piquet, M., Jc, V., & Dao, T. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)95217-7 · Cited by 14
Patients with Autonomic Neuropathy Are More Likely to Develop Hepatic Encephalopathy
Maheshwari, A., Thomas, A., & Thuluvath, P. J. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000043368.73042.b0 · Cited by 14
Effects of Rifaximin on Bacterial Translocation in Thioacetamide-Induced Liver Injury in Rats
Harputluoglu, M. M. M., Demirel, U., Gül, M., Temel, İ., Gürsoy, Ş., Selçuk, E. B., Aladağ, M., Bilgiç, Y., Gündüz, E., & Seçkın, Y. (2012) · Inflammation · doi:10.1007/s10753-012-9465-2 · Cited by 13
Enteric Microbiota and Small Intestinal Bacterial Overgrowth
O’Mahony, S., & Shanahan, F. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00102-5 · Cited by 12
Xu, H., Xiong, J., Xu, J., Li, S., Zhou, Y., Chen, D., Cai, X., Jian, P., Deng, M., & Chen, J. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4704-x · Cited by 12
Li, F.-C., Li, Y., Fan, Y., & Wang, K. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.05.050 · Cited by 11
Dahabra, L., Kreidieh, M., Abureesh, M., Yassine, A. A., & Deeb, L. S. (2022) · Gastroenterology Research · doi:10.14740/gr1545 · Cited by 11
Gastrointestinal Dysfunction in Chronic Liver Disease
Nguyen, D. H. N. Q. (2015) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000257 · Cited by 10
Li, F.-C., Fan, Y., Li, Y., & Wang, K. (2019) · Virology Journal · doi:10.1186/s12985-019-1219-4 · Cited by 10
Infection et rupture de varice œsophagienne au cours de la cirrhose
Boursier, J., Asfar, P., Joly‐Guillou, M., & Calès, P. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89324-9 · Cited by 10
Cisapride decreasing orocecal transit time in patients with nonalcoholic steatohepatitis.
Fu, X., & Jiang, F. Y. (2006) · PubMed · Cited by 9
Therapeutic strategies and emergence of multiresistant bacterial strains
Salerno, F., & Cazzaniga, M. (2010) · Internal and Emergency Medicine · doi:10.1007/s11739-010-0447-9 · Cited by 9
Translocation bactérienne : mythe ou réalité ?
Plantefève, G., & Bleichner, G. (2001) · Réanimation · doi:10.1016/s1164-6756(01)00154-2 · Cited by 9
Comment traiter et prévenir l’infection du liquide d’ascite ?
Grangé, J. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)95267-0 · Cited by 8
Markers of immunity and bacterial translocation in cirrhosis.
Mortensen, C. (2015) · PubMed · Cited by 7
García–Tsao, G. (2001) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200105000-00012 · Cited by 7
Soylu, A. R., Dökmeci, G., Tezel, A., Amuca, H., & Ümit, H. C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07507.x · Cited by 7
Zhang, Q., Li, H., Chen, C., Li, M., Song, J., Pan, S., Shen, B., & Huang, Y. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251399033 · Cited by 7
Consecuencias patogénicas de la translocación bacteriana en la cirrosis hepática
Albillos, A., de la Hera, A., & Álvarez‐Mon, M. (2001) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(01)79001-2 · Cited by 6
Mustafa, F., Noor, R., Murtaza, A., Kanwal, W., Kanwal, F., Kaleem, T., Munir, F., Umar, R. A. B., Taib, W. R. W., Krishnasamy, S., et al. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128373584250407134451 · Cited by 5
Mechanisms and pathophysiology leading to development of small intestinal microbial dysbiosis
Damianos, J., Wang, X. J., & Camilleri, M. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00295-x · Cited by 5
Xirouchakis, E., Kranidioti, H., Hadziyanni, E., Κourikou, A., Reppas, C. I., Vertzoni, M., Papadopoulos, N., Deutsch, M. J., Papatheodoridis, G., & Manolakopoulos, S. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03483-6 · Cited by 5
Young, P. E., Dobhan, R. R., & Schafer, T. W. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2717-3 · Cited by 5
Popoiag, R.-E., Stoian, A. P., Suceveanu, A. P., Suceveanu, A., Mazilu, L., Parepa, I. R., Serban, L., Păunică, M., Motofei, C., & Fierbinteanu-Braticevici, C. G. (2019) · Journal of Mind and Medical Sciences · doi:10.22543/7674.61.p2630 · Cited by 5
Pathogenesis and Clinical Features of Spontaneous Bacterial Peritonitis
Such, J. M., Guarner, C., & Runyon, B. A. (2005) · Wiley eBooks · doi:10.1002/9780470987476.ch34 · Cited by 5
Kosáková, D., Scheer, P., Lata, J., & Doubek, J. (2007) · Veterinární Medicína · doi:10.17221/2013-vetmed · Cited by 4
Infection au cours de la cirrhose
Grangé, J. (2006) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(06)73338-3 · Cited by 3
Spontaneous bacterial peritonitis in cirrhotic patients - case report
Hecser, L., Siklodi, K. P., Croitorescu, L., & Jung, H. (2009) · Romanian Journal of Legal Medicine · doi:10.4323/rjlm.2009.187 · Cited by 3
Liver cirrhosis-epidemiological and Clinical Aspects
Gunnarsdóttir, S. A. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 3
Microbiota, Inflammation, and Gut Barrier Dysfunction in HCC
Ram, A. K., Wright, G. A. K., & Vairappan, B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89578 · Cited by 2
Bacterial Translocation and Alterations of the Digestive System
Wiest, R. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_10 · Cited by 2
Hsieh, Y., Lee, M., Lee, K., Yang, Y., Hou, M., & Lin, H. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2018.01.013 · Cited by 2
Khan, T. U., Khan, W., & Iqbal, S. (2020) · The Professional Medical Journal · doi:10.29309/tpmj/2020.27.03.968 · Cited by 2
Òdena, G., Cabré, E., Galán, A., Planas, R., & Bartolí, R. (2009) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2009.08.004 · Cited by 2
Self-citationExperimental Models of Spontaneous Bacterial Peritonitis
Albillos, A., de la Hera, A., & Álvarez‐Mon, M. (2005) · Wiley eBooks · doi:10.1002/9780470987476.ch33 · Cited by 3
Failure of acarbose in preventing bacterial translocation in experimental cirrhosis
Sevá‐Pereira, T., Fernández, J., Navasa, M., Vilà, J., & Rodés, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00234-4 · Cited by 2
Spontaneous Bacterial Peritonitis and Other Infections in Cirrhosis
Morillas, R. M., & Planas, R. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-885-4_21 · Cited by 1
Self-citationSpontaneous Bacterial Peritonitis: Is It Still A Life-Threatening Issue in Cirrhosis?
Ribeiro, T. C. D. R. (2016) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2016.05.616 · Cited by 1
Modulation of intestinal flora for the treatment of hepatic encephalopathy in cirrhosis
Galhenage, S., Almeida, J. A., Yu, J., Kurtovic, J., Segal, I., & Riordan, S. M. (2007) · Springer eBooks · doi:10.1007/1-4020-4456-9_44 · Cited by 1
The Gut Microbiome and Cirrhosis: Basic Aspects
Wiest, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-23018-4_18 · Cited by 2
Spontaneous Bacterial Peritonitis – Prophylaxis and Treatment
Wiest, R., & Garcia-Tsao, G. (2011) · Frontiers of gastrointestinal research · doi:10.1159/000318963
Mulyadi, Y., Gani, R. A., Abdullah, M., & Shatri, H. (2012) · The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy · doi:10.24871/1332012130-135
Infecci?n bacteriana en la cirrosis hep?tica
Amors, A., & Such, J. M. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73142-4
Klinische Strategien zur Pr�vention der bakteriellen Translokation bei kritisch kranken Patienten
Druml, W. (2001) · Intensivmedizin und Notfallmedizin · doi:10.1007/s003900170014
Cirrosis hepática: medidas preventivas de algunas de sus complicaciones
Toledo, A. (2010) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(10)70597-6
Kosáková, D., Scheer, P., Lata, J., & Doubek, J. (2007) · Acta Veterinaria Brno
Fisiopatología de las infecciones bacterianas en la cirrosis
(2006) · Gastroenterología y Hepatología Continuada · doi:10.1016/s1578-1550(06)74267-x
PREBIÓTICOS Y PROBIÓTICOS: MECANISMOS DE ACCIÓN Y SUS APLICACIONES CLÍNICAS
Clínicas, E. I. (2016)
TESIS PARA OPTAR AL GRADO DE DOCTOR DE
de Medicina, D., & de Medicina, F. (2015)
Garcia, G. Ò. (2011) · TDX (Tesis Doctorals en Xarxa)
Long-term Impacts of Early Life Antibiotic Exposure on Intestinal Microbiota and Metabolic Disease
Li, J. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3rv0db74
Sherlock, F. S., & BSc, J. D. (2001) · doi:10.1002/9780470986820.ch21
CLINICALLY IMPORTANT BACTERIAL INFECTIONS IN CIRRHOSIS
Гавриленко, Д. И. (2011) · Health and Ecology Issues · doi:10.51523/2708-6011.2011-8-3-8
SOME ASPECTS OF PATHOGENESIS AND DIAGNOSTICS OF SPONTANEOUS BACTERIAL PERITONITIS
Гавриленко, Д. И. (2009) · Health and Ecology Issues · doi:10.51523/2708-6011.2009-6-4-8
Padhi, P. K., Patra, S., & Bagudai, A. K. (2024) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2024.v84i03.003
Whitehead, B. A., & Bass, L. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11760-2.00077-x
Camilleri, M., & Damianos, J. (2026) · Neurogastroenterology & Motility · doi:10.1111/nmo.70257
Metadata
- Authors
- Pardo, A., Bartolí, R., Lorenzo-Zúñiga, V., Planas, R., Viñado, B., Riba, J., Cabré, E., Santos, J., Luque, T., Ausina, V., & Gassull, M. A.
- Affiliations
- Hospital Universitari Germans Trias i Pujol (ES)
- Venue
- Hepatology
- Published
- 2000-04
- Volume
- 31
- Issue
- 4
- Pages
- 858-863
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2013027212
- Cited by
- 177
- References
- 42
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 9 · 2018: 6 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 12 · 2013: 2 · 2012: 7
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Gastroenterological Association
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- cisapride, intestinal bacterial overgrowth, bacterial translocation, liver cirrhosis, intestinal motility, Gram-negative bacteria, orocecal transit time
- MeSH terms
- Adolescent, Adult, Aged, Animals, Bacteria, Female, Gastrointestinal Agents, Humans, Intestines, Liver Cirrhosis, Liver Cirrhosis, Experimental, Male, Middle Aged, Pilot Projects, Rats, Sprague-Dawley, Bacterial Translocation, Cisapride, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review